Management Quality -- 8.5/10

CEO Tim Archer has led Lam Research since 2018, navigating the full WFE cycle from peak to trough and back to record highs. Management has beaten revenue and EPS guidance midpoints for 5 consecutive quarters, returned 85% of FCF to shareholders, and reduced the share count by ~3.2% over 5 quarters. The Investor Day roadmap to double revenue and profit over five years is already running ahead of schedule with operating margins hitting 34-35% well before the model implied. Weight: 20%
CEO Tenure
Since 2018
Timothy Archer, full-cycle leader
Guidance Beat Streak
5/5 Quarters
Rev and EPS above midpoint every Q
FCF Return to Shareholders
85% of FCF
Within 75-100% target range
Share Count Decline
~3.2% in 5Q
1,304M to 1,262M diluted
WFE Guidance Accuracy
Year WFE Guide Actual Verdict
CY2024 Mid-$90B range Mid-$90B Accurate
CY2025 $100B (raised to $105B mid-year) ~$110B Conservative initial, accurate direction
CY2026 ~$135B (+23% YoY) TBD Bold call backed by clean room constraints
Source: Earnings call transcripts FY2025-FY2026.

Promise Tracking
Promise Result Status
Investor Day: Double revenue and profit over 5 years (Feb 2025) CY2025 record $20.6B rev, up 27% YoY ON TRACK
Op margin model: 34-35% at $25-27B revenue Already hitting 34-35% at ~$21B run rate -- ahead of plan BEAT
SAM expansion: low-30s to high-30s % of WFE Progressed to mid-30s in CY2025, gained 1+ pp share ON TRACK
CSBG: Installed base to 100K chambers Crossed 100K in CY2025; CSBG record $7.2B DELIVERED
Capital return: 75-100% of FCF Returned 85% of FCF in CY2025; ~39M shares repurchased DELIVERED
Source: Investor Day (Feb 2025), FY2025-FY2026 earnings transcripts.

Guidance vs. Actuals (Last 5 Quarters)
Quarter Rev Guide Rev Actual Rev Beat EPS Guide EPS Actual EPS Beat
CY24Q4 (FY25Q2) $4.30B $4.38B +1.8% $1.00 $0.91 Note*
CY25Q1 (FY25Q3) $4.65B $4.72B +1.5% $1.00 $1.04 +4.0%
CY25Q2 (FY25Q4) $5.00B $5.17B +3.4% $1.20 $1.33 +10.8%
CY25Q3 (FY26Q1) $5.20B $5.32B +2.3% $1.15 $1.26 +9.6%
CY25Q4 (FY26Q2) $5.20B $5.34B +2.7% $1.15 $1.27 +10.4%
*CY24Q4 EPS: pre-split guide vs. post-split actual makes direct comparison misleading. Gross margin and operating margin consistently at or above high end of guided ranges.
Source: Daloopa, earnings call transcripts.

Capital Allocation
MetricCY24Q2CY24Q3CY24Q4CY25Q1CY25Q2CY25Q3CY25Q4YoY
Buybacks ($M)$374--$650$347$1,307$990$1,442+122%
Dividends ($M)$261$261$298$296$295$292$328+10%
CY2025 buybacks totaled ~39M shares at an average price of ~$104/share. Dividends increased from $0.23 to $0.26 per share in 2025, consistent with a progressive dividend policy.
Diluted Share Count (Declining)
QuarterCY24Q3CY24Q4CY25Q1CY25Q2CY25Q3CY25Q4
Shares (M)1,3041,2911,2881,2771,2691,262
Steady decline of ~3.2% over 5 quarters through aggressive buybacks. Management targets continued share count reduction, funded by strong FCF generation (~$6.2B annualized as of FY2026H1).

Score Rationale
8.5/10. CEO Tim Archer (since 2018) has navigated the full WFE cycle and delivered record results in the upcycle. The 5/5 guidance beat streak, 85% FCF return rate, and steady share count reduction demonstrate disciplined capital allocation. The Investor Day operating margin target is already being achieved ahead of schedule. SAM expansion and CSBG installed base milestones are on track. Minor deductions: (1) gross margin guided slightly lower for CY26Q3 on customer mix headwinds, showing some sensitivity to China normalization; (2) WFE guidance has tended to start conservative and ratchet up, which is a positive pattern but makes initial calls less informative. Not a 9 because the cycle is still early and the multi-year doubling promise remains largely ahead of the team.

Data sourced from Daloopa, earnings call transcripts, and company disclosures.